YU163681A - Process for obtaining compounds of mucolytic activity which are not absorbed in tissues - Google Patents
Process for obtaining compounds of mucolytic activity which are not absorbed in tissuesInfo
- Publication number
- YU163681A YU163681A YU01636/81A YU163681A YU163681A YU 163681 A YU163681 A YU 163681A YU 01636/81 A YU01636/81 A YU 01636/81A YU 163681 A YU163681 A YU 163681A YU 163681 A YU163681 A YU 163681A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- tissues
- absorbed
- mucolytic activity
- obtaining compounds
- mucolytic
- Prior art date
Links
- 230000000510 mucolytic effect Effects 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title 1
- 102000035195 Peptidases Human genes 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 235000014633 carbohydrates Nutrition 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229920002521 macromolecule Polymers 0.000 abstract 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 abstract 1
- 125000003396 thiol group Chemical group [H]S* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/10—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
- C12N11/082—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
- C12N11/082—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds
- C12N11/087—Acrylic polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/21—Endodeoxyribonucleases producing 5'-phosphomonoesters (3.1.21)
- C12Y301/21001—Deoxyribonuclease I (3.1.21.1)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT8023161A IT1209419B (it) | 1980-07-01 | 1980-07-01 | Composti ad attivita' mucolitica non assimilabili, processo per laloro preparazione e composizioni terapeutiche che li comprendono come principio attivo. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU163681A true YU163681A (en) | 1983-09-30 |
Family
ID=11204417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU01636/81A YU163681A (en) | 1980-07-01 | 1981-07-01 | Process for obtaining compounds of mucolytic activity which are not absorbed in tissues |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US4409138A (enExample) |
| EP (1) | EP0045285B1 (enExample) |
| JP (1) | JPS5813522A (enExample) |
| AT (1) | ATE7202T1 (enExample) |
| AU (1) | AU7241281A (enExample) |
| CA (1) | CA1168169A (enExample) |
| DE (1) | DE3163287D1 (enExample) |
| ES (1) | ES503527A0 (enExample) |
| FR (1) | FR2485925A1 (enExample) |
| IT (1) | IT1209419B (enExample) |
| YU (1) | YU163681A (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU574360B2 (en) * | 1983-05-13 | 1988-07-07 | Reichert, D. | Antisnoring agent |
| US4585754A (en) * | 1984-01-09 | 1986-04-29 | Valcor Scientific, Ltd. | Stabilization of proteins and peptides by chemical binding with chondroitin |
| CA1317860C (en) * | 1987-04-01 | 1993-05-18 | Daniel Louis Kacian | Techniques for preparing specimens for bacterial assays |
| US5128132A (en) * | 1988-11-22 | 1992-07-07 | Parnell Pharmaceuticals, Inc. | Eriodictyon compositions and methods for treating internal mucous membranes |
| DE60207811T2 (de) * | 2001-07-03 | 2006-06-29 | Alcon Inc. | Zusammensetzungen zur entfernung von menschlichem cerumen |
| US20060182705A1 (en) * | 2005-02-11 | 2006-08-17 | Cruse Maria K | Composition for reduction and prevention of wrinkles on the skin |
| EP3797783A1 (en) * | 2019-09-27 | 2021-03-31 | Freie Universität Berlin | Novel medical uses of thiol-functionalized polyglycerol derivatives |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR924877A (fr) * | 1946-03-15 | 1947-08-19 | Procédé de fabrication de préparations vétérinaires | |
| US4004979A (en) * | 1968-03-29 | 1977-01-25 | Agence Nationale De Valorisation De La Recherche (Anvar) | Preparation of active proteins cross-linked to inactive proteins |
| NL6812443A (enExample) * | 1968-08-31 | 1970-03-03 | ||
| BE758425A (fr) * | 1969-12-02 | 1971-04-16 | Baxter Laboratories Inc | Streptokinase liee chimiquement a une matrice en carbohydrate ( |
| US3683069A (en) * | 1970-02-19 | 1972-08-08 | Michel Hooreman | Enzymatic products which optimize the viscosity of mucuses and their applications |
| JPS5443074B1 (enExample) * | 1971-04-14 | 1979-12-18 | ||
| BE790326A (fr) * | 1971-10-20 | 1973-04-19 | Pechiney Ugine Kuhlmann | Nouveau derive d'hydroxyquinoleine |
| US4185090A (en) * | 1972-02-02 | 1980-01-22 | Abbott Laboratories | Chemically modified endotoxin immunizing agent |
| GB1479268A (en) * | 1973-07-05 | 1977-07-13 | Beecham Group Ltd | Pharmaceutical compositions |
| SE431758B (sv) * | 1977-03-04 | 1984-02-27 | Pharmacia Fine Chemicals Ab | Som tioleringsreagens eller berarmatris for enzymer anvendbart derivat av en sh-grupphaltig polymer |
| CS204190B1 (en) * | 1978-02-22 | 1981-03-31 | Jaroslav Drobnik | Activation method for hydrxyl groups containing insoluble carriers |
| US4259233A (en) * | 1979-10-23 | 1981-03-31 | Miles Laboratories, Inc. | β-Galactosyl-umbelliferone-labeled protein and polypeptide conjugates |
-
1980
- 1980-07-01 IT IT8023161A patent/IT1209419B/it active
- 1980-08-11 FR FR8017656A patent/FR2485925A1/fr active Granted
- 1980-09-05 US US06/184,249 patent/US4409138A/en not_active Expired - Lifetime
-
1981
- 1981-06-19 AT AT81830099T patent/ATE7202T1/de not_active IP Right Cessation
- 1981-06-19 DE DE8181830099T patent/DE3163287D1/de not_active Expired
- 1981-06-19 EP EP81830099A patent/EP0045285B1/en not_active Expired
- 1981-06-29 CA CA000380788A patent/CA1168169A/en not_active Expired
- 1981-06-30 AU AU72412/81A patent/AU7241281A/en not_active Abandoned
- 1981-06-30 ES ES503527A patent/ES503527A0/es active Granted
- 1981-07-01 YU YU01636/81A patent/YU163681A/xx unknown
- 1981-07-01 JP JP56101394A patent/JPS5813522A/ja active Pending
-
1983
- 1983-07-11 US US06/512,679 patent/US4559322A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US4409138A (en) | 1983-10-11 |
| FR2485925A1 (fr) | 1982-01-08 |
| DE3163287D1 (en) | 1984-05-30 |
| AU7241281A (en) | 1982-01-07 |
| ES8203420A1 (es) | 1982-04-01 |
| IT8023161A0 (it) | 1980-07-01 |
| US4559322A (en) | 1985-12-17 |
| FR2485925B1 (enExample) | 1985-05-24 |
| CA1168169A (en) | 1984-05-29 |
| JPS5813522A (ja) | 1983-01-26 |
| ATE7202T1 (de) | 1984-05-15 |
| EP0045285B1 (en) | 1984-04-25 |
| ES503527A0 (es) | 1982-04-01 |
| EP0045285A1 (en) | 1982-02-03 |
| IT1209419B (it) | 1989-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA979805A (en) | Method for isolation of antithrombin from animal tissue material by adsorption on sulfated carbohydrate gel | |
| NL191308C (nl) | Gelyofiliseerd, na oplossing injecteerbaar preparaat dat een antracycline-glycoside bevat, alsmede werkwijze voor de bereiding van een injecteerbare oplossing van een antracycline-glycoside. | |
| YU163681A (en) | Process for obtaining compounds of mucolytic activity which are not absorbed in tissues | |
| EP0191357A3 (en) | Treatment of eye inflammation with biphenamine | |
| MX7551E (es) | Procedimiento mejorado para la isomerizacion enzimatica de glucosa en fructosa | |
| ES309630A1 (es) | Procedimiento de preparacion de un material anticoagulante. | |
| JPS53136528A (en) | Cosmetics | |
| ES2126575T3 (es) | Sacarosa-fosfato-sintasa (sps), su procedimiento de preparacion, su adnc, y utilizacion de adnc para modificar la expresion de sps en celulas vegetales. | |
| YU37476A (en) | Rocess for obtaining an immobilized enzymatic conjugate | |
| ES426414A1 (es) | Metodo para producir una preparacion de ciclocitidina seca-da por congelacion. | |
| JPS523892A (en) | Method of enzyme immobilization | |
| JPS5437889A (en) | Preparation of polysaccharide | |
| ES486851A1 (es) | Un procedimiento de preparacion de acido 3a,7b-dihidroxico- lanico | |
| JPS5264494A (en) | Preparation of fr-1923 substance | |
| ES2070127T3 (es) | Procedimiento para preparar n-acil-anilinas. | |
| JPS53124682A (en) | Preparation of complex of enzyme and bioactive substance and its use | |
| DE2961506D1 (en) | N-cyclohexyl-n-methoxy-acetoacetamide, process for its preparation and its use to prepare o-methyl-n-cyclohexyl-2,5-dimethyl-furane-3-hydroxamic acid | |
| JPS53130486A (en) | Preparation of immobilized enzyme | |
| ES441849A1 (es) | Procedimiento para el tratamiento de celulas de microorga- nismos. | |
| GR3003950T3 (enExample) | ||
| JPS5257392A (en) | Immobilized enzyme using fibroin as carrier and method of preparing th e same | |
| JPS5416033A (en) | Ignition distributor | |
| ES375480A1 (es) | Un procedimiento en la produccion de composiciones depila- doras. | |
| JPS5399387A (en) | Immobilized enzyme and process for its preparation | |
| JPS5297955A (en) | Preparation of hydroxylaminoanthraquinones |